The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study
Abstract
Abdominal fat distribution is influenced by androgen levels in both men and women. The purpose of this study was to assess the effects on fat distribution of administering nandrolone decanoate (ND; an anabolic steroid with weak androgenic activity) or spironolactone (SP; an antiandrogen) in obese postmenopausal women. The design was a randomized, placebo-controlled, 9-month trial with simultaneous calorie restriction for weight loss. Women in all three groups lost comparable amounts of weight, but the ND-treated women gained lean mass relative to the other two groups (P < 0.0005) and lost more body fat than women in the SP group (P < 0.01). The resting metabolic rate also increased slightly in the ND group. ND treatment produced a gain in visceral fat, as determined by computed tomography scan, and a relatively greater loss of sc abdominal fat. SP-treated women lost significantly less sc fat than the other two groups. Serum cholesterol decreased in the placebo group, but increased slightly in the other two groups (significant for SP vs. placebo, P < 0.05). High density lipoprotein cholesterol decreased significantly in the ND-treated women. There were no significant changes in fasting glucose or insulin sensitivity. We conclude that administration of exogenous androgens modulates body composition in obese postmenopausal women and independently affects visceral and sc abdominal fat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Androgen Treatment of Abdominally Obese Men
Mårin, P., Holmtäng, S., Gustafsson, C., Jönsson, ‡., Kvist, ‡., Elander, A., Eldh, J., Sjöström, L., Holm, G., & Björntorp, P. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00618.x · Cited by 345
Cited by
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Do stress reactions cause abdominal obesity and comorbidities?
Björntorp, P. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00027.x · Cited by 1,138
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Gender differences in insulin resistance, body composition, and energy balance
Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Obesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635
Smith, S. R., Lovejoy, J. C., Greenway, F., Ryan, D., deJonge, L., de la Bretonne, J., Volafova, J., & Bray, G. A. (2001) · Metabolism · doi:10.1053/meta.2001.21693 · Cited by 596
Self-citationAndrogens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592
Obesity and androgens: facts and perspectives
Pasquali, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.054 · Cited by 469
Obesity and the pubertal transition in girls and boys
Burt Solorzano, C. M., & McCartney, C. R. (2010) · Reproduction · doi:10.1530/rep-10-0119 · Cited by 453
Sex differences in obesity and the regulation of energy homeostasis
Lovejoy, J. C., Sainsbury, A., & the Stock Conference 2008 Working Group (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00529.x · Cited by 421
Self-citationCurrent and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 331
Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J. M., & T'Sjoen, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0493 · Cited by 329
Androgens and body fat distribution
Blouin, K., Boivin, A., & Tchernof, A. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.001 · Cited by 309
Androgen therapy in women: An Endocrine Society clinical practice guideline
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1121 · Cited by 301
Sex dimorphism and depot differences in adipose tissue function
White, U. A., & Tchoukalova, Y. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.006 · Cited by 284
Clinical Applications of Body Composition Measurements Using DXA
Albanese, C. V., Diessel, E., & Genant, H. K. (2003) · Journal of Clinical Densitometry · doi:10.1385/jcd:6:2:75 · Cited by 276
Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women
Ko, S.-H., & Jung, Y. (2021) · Nutrients · doi:10.3390/nu13124556 · Cited by 275
Elbers, J. M. H., Asscheman, H., Seidell, J. C., & Gooren, L. J. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.2.e317 · Cited by 236
Gambineri, A., Patton, L., Vaccina, A., Cacciari, M., Morselli-Labate, A. M., Cavazza, C., Pagotto, U., & Pasquali, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2250 · Cited by 221
Gambineri, A., Pelusi, C., Genghini, S., Morselli‐Labate, A. M., Cacciari, M., Pagotto, U., & Pasquali, R. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01973.x · Cited by 216
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study
Ding, E. L., Song, Y., Manson, J. E., Rifai, N., Buring, J. E., & Liu, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0785-y · Cited by 208
“Further, testosterone therapy has been shown to induce insulin resistance in female-to-male transsexual [25] and increase visceral adiposity in postmenopausal women [26], whereas anti-androgen therapy decreases visceral adiposity in obese women with polycystic ovarian syndrome [27] and improves insulin sensitivity in…”
BackgroundAdiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study
Escobar-Morreale, H. F. (2006) · Human Reproduction · doi:10.1093/humrep/del146 · Cited by 200
Kalyani, R. R., Franco, M., Dobs, A. S., Ouyang, P., Vaidya, D., Bertoni, A., Gapstur, S. M., & Golden, S. H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0910 · Cited by 179
Exercise Training Prevents Regain of Visceral Fat for 1 Year Following Weight Loss
Hunter, G. R., Brock, D. W., Byrne, N. M., Chandler‐Laney, P. C., Del Corral, P., & Gower, B. A. (2010) · Obesity · doi:10.1038/oby.2009.316 · Cited by 136
“Cortisol (39), exogenous androgens (40), and dopamine (41) may increase storage of fat in the viscera, whereas growth hormone (39) may have a negative effect on storage of fat in the viscera in women.”
BackgroundNilsson, C., Niklasson, M., Eriksson, E., Björntorp, P., & Holmäng, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1353 · Cited by 103
Ibáñez, L., Ong, K., Ferrer, A., Amin, R., Dunger, D., & de Zegher, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022002 · Cited by 100
Sex-dependent depot differences in adipose tissue development and function; role of sex steroids
Lee, M.-J., & Fried, S. K. (2017) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2017.26.3.172 · Cited by 72
Tolino, A., Gambardella, V., Caccavale, C., D’Ettore, A., Giannotti, F., D’Antò, V., & De Falco, C. L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.06.043 · Cited by 69
Covariation of change in bioavailable testosterone and adiposity in midlife women
Janssen, I., Powell, L. H., Jasielec, M. S., & Kazlauskaite, R. (2015) · Obesity · doi:10.1002/oby.20974 · Cited by 51
“The impact of BioT on VAT was further supported by a clinical trial where administration of a weak androgen (nandrolone decanoate), resulted in an increase of VAT in obese women (27).”
BackgroundZang, H., Rydén, M., Wåhlen, K., Dahlman-Wright, K., Arner, P., & Hirschberg, A. L. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.088 · Cited by 47
Christiansen, J. J., Bruun, J. M., Christiansen, J. S., Jørgensen, J. O., & Gravholt, C. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0289 · Cited by 26
Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Papaetis, G. S., Filippou, P. K., Constantinidou, K. G., & Stylianou, C. S. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00942-2 · Cited by 25
Venkatesh, V. S., Grossmann, M., Zajac, J. D., & Davey, R. A. (2022) · Obesity Reviews · doi:10.1111/obr.13429 · Cited by 22
Metadata
- Authors
- Lovejoy, J. C.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1996-06-01
- Volume
- 81
- Issue
- 6
- Pages
- 2198-2203
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2093863215
- Cited by
- 216
- References
- 3
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.